| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.2 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | 0.19 | 0.2 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |